Received Feb 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | OT |
82 year old patient received prescription of Adacel with no adverse event; Initial information received on 09-Feb-2026 regarding an unsolicited valid non-serious case received from a physician. This case involves a 82 years old and unknown gender patient who received intentional prescription of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received intentional prescription of 0.5 ml suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE, Suspension for injection (dose, strength, lot, expiry and administration site: unknown) via intramuscular route with no adverse event (product prescribing issue) (latency same day) for helps protect against tetanus, diphtheria, and pertussis (immunization). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Reportedly:- Adacel is approved for use in persons 10 through 64 years of age Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.